80386-6
LaboratoryBladder tumor Ag [Presence] in Urine by Rapid immunoassay
Definition
This term was created for, but is not limited in use to, the bioMerieux bioNexia BTA assay, which is intended for the qualitative detection of bladder tumor-associated antigen (BTA) in human urine specimens. The test is indicated for use as an aid for screening high-risk populations and monitoring bladder cancer patients. The bioNexia BTA assay results should be read 5-6 minutes after the sample is applied to the sample well.
LOINC 6-Axis Classification
Component
Bladder tumor Ag
Property
PrThr
Time Aspect
Pt
System
Urine
Scale Type
Ord
Method Type
IA.rapid
Details
Class
SERO
Order/Observation
Both
Short Name
Bladder tumor Ag Ur Ql IA.rapid
Display Name
Bladder tumor Ag IA.rapid Ql (U)
Related Names
Frequently Asked Questions
What is LOINC code 80386-6?
LOINC code 80386-6 identifies "Bladder tumor Ag [Presence] in Urine by Rapid immunoassay". This term was created for, but is not limited in use to, the bioMerieux bioNexia BTA assay, which is intended for the qualitative detection of bladder tumor-associated antigen (BTA) in human urine specimens. The test is indicated for use as an aid for screening high-risk populations and monitoring bladder cancer patients. The bioNexia BTA assay results should be read 5-6 minutes after the sample is applied to the sample well.
What does 80386-6 measure?
This code measures Bladder tumor Ag in Urine. It belongs to the SERO class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.